Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western India
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiae240 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Avika Dixit und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant, Drug Resistance, Multiple, Bacterial, Tuberculosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases, NIAID NIH HHS, US Civilian Research and Development Foundation (CRDF).
Abstract (Originalsprache)
Background
Drivers of tuberculosis (TB) transmission in India, the country estimated to carry a quarter of the world's burden, are not well studied. We conducted a genomic epidemiology study to compare epidemiological success, host factors, and drug resistance among the 4 major Mycobacterium tuberculosis (Mtb) lineages (L1–L4) circulating in Pune, India.
Methods
We performed whole-genome sequencing (WGS) of Mtb sputum culture–positive isolates from participants in two prospective cohort studies and predicted genotypic susceptibility using a validated random forest model. We compared lineage-specific phylogenetic and time-scaled metrics to assess epidemiological success.
Results
Of the 612 isolates that met sequence quality criteria, Most were L3 (44.6%). The majority (61.1%) of multidrug-resistant isolates were L2 (P < .001) and L2 demonstrated a higher rate and more recent resistance acquisition. L4 and/or L2 demonstrated higher clustering and time-scaled haplotypic density (THD) compared to L3 and/or L1, suggesting higher epidemiological success. L4 demonstrated higher THD and clustering (odds ratio, 5.1 [95% confidence interval, 2.3–12.3]) in multivariate models controlling for host factors and resistance.
Conclusions
L2 shows a higher frequency of resistance, and both L2 and L4 demonstrate evidence of higher epidemiological success than L3 or L1 in Pune. Contact tracing around TB cases and heightened surveillance of TB DR in India is a public health priority.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.
- Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
- Byramjee-Jeejeebhoy Government Medical College, Pune, India.
- Center for Clinical Global Health Education, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Trials Unit, Pune, India.
ORCID-Profile: Amita Gupta, Vidya Mave, Maha Farhat
Förderung
- National Institute of Allergy and Infectious Diseases
- NIAID NIH HHS
- US Civilian Research and Development Foundation (CRDF)
- NHGRI NIH HHS
- German Research Foundation
- Indo-US Medical Partnership
- BTREC
- Boston Children's Hospital OFD
Zitieren
APA
Dixit, A., Ektefaie, Y., Kagal, A., Freschi, L., Karyakarte, R., Lokhande, R., Groschel, M., Tornheim, J. A., Gupte, N., Pradhan, N. N., Paradkar, M. S., Deshmukh, S., Kadam, D., Schito, M., Engelthaler, D. M., Gupta, A., Golub, J., Mave, V., & Farhat, M. (2025). Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western India. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae240
Vancouver
Dixit A, Ektefaie Y, Kagal A, Freschi L, Karyakarte R, Lokhande R, et al. Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western India. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiae240
BibTeX
@article{Dixit2025,
author = {Dixit, Avika and Ektefaie, Yasha and Kagal, Anju and Freschi, Luca and Karyakarte, Rajesh and Lokhande, Rahul and Groschel, Matthias and Tornheim, Jeffrey A and Gupte, Nikhil and Pradhan, Neeta N and Paradkar, Mandar S and Deshmukh, Sona and Kadam, Dileep and Schito, Marco and Engelthaler, David M and Gupta, Amita and Golub, Jonathan and Mave, Vidya and Farhat, Maha},
title = {Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western India},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiae240}
}
EUVIMED